Abordo, Ronisa .
HRN: 17-06-02 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/02/2023
CEFAZOLIN 1GM (VIAL)
03/02/2023
03/02/2023
IV
2 Grams
1
Repeat CS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes